BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8217544)

  • 1. Long-term cerebral effects of CNS chemotherapy in children with acute lymphoblastic leukemia.
    Bakke SJ; Fossen A; Storm-Mathiesen I; Lie SO
    Pediatr Hematol Oncol; 1993; 10(3):267-70. PubMed ID: 8217544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
    Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
    Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
    J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate.
    Asato R; Akiyama Y; Ito M; Kubota M; Okumura R; Miki Y; Konishi J; Mikawa H
    Cancer; 1992 Oct; 70(7):1997-2004. PubMed ID: 1525778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
    Kingma A; Van Dommelen RI; Mooyaart EL; Wilmink JT; Deelman BG; Kamps WA
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):106-14. PubMed ID: 11990695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
    Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
    Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Late sequelae of CNS recurrence of acute lymphoblastic leukemia in childhood].
    Steinberg S; Hartmann R; Wisniewski S; Berger K; Beck JD; Henze G
    Klin Padiatr; 1998; 210(4):200-6. PubMed ID: 9743953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging and neurological evaluation after treatment with high-dose methotrexate for acute lymphocytic leukaemia in young children.
    Seidel H; Nygaard R; Haave I; Moe PJ
    Acta Paediatr; 1996 Apr; 85(4):450-3. PubMed ID: 8740303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychologic sequelae in the long-term survivors of childhood acute lymphoblastic leukemia.
    Cetingül N; Aydinok Y; Kantar M; Oniz H; Kavakli K; Yalman O; Erermiş S; Celebisoy N; Akyürekli O; Oztop S; Nişli G
    Pediatr Hematol Oncol; 1999; 16(3):213-20. PubMed ID: 10326219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia: association with attention deficits.
    Brouwers P; Poplack D
    Am J Pediatr Hematol Oncol; 1990; 12(2):174-81. PubMed ID: 2116096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter changes in children treated for acute lymphoblastic leukemia.
    Pääkkö E; Vainionpää L; Lanning M; Laitinen J; Pyhtinen J
    Cancer; 1992 Dec; 70(11):2728-33. PubMed ID: 1423204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
    J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cross-sectional Study of Two Chemotherapy Protocols on Long Term Neurocognitive Functions in Egyptian Children Surviving Acute Lymphoblastic Leukemia.
    Sherief LM; Sanad R; ElHaddad A; Shebl A; Abdelkhalek ER; Elsafy ER; Hassan TH; Raafat N; Kamal NM; Attia EI
    Curr Pediatr Rev; 2018; 14(4):253-260. PubMed ID: 30381081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation.
    Reddick WE; Glass JO; Helton KJ; Langston JW; Li CS; Pui CH
    AJNR Am J Neuroradiol; 2005 Oct; 26(9):2371-7. PubMed ID: 16219848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL--an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working Group.
    Hertzberg H; Huk WJ; Ueberall MA; Langer T; Meier W; Dopfer R; Skalej M; Lackner H; Bode U; Janssen G; Zintl F; Beck JD
    Med Pediatr Oncol; 1997 Jun; 28(6):387-400. PubMed ID: 9143382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings.
    Pääkkö E; Harila-Saari A; Vanionpää L; Himanen S; Pyhtinen J; Lanning M
    Med Pediatr Oncol; 2000 Nov; 35(5):456-61. PubMed ID: 11070477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features.
    Ziereisen F; Dan B; Azzi N; Ferster A; Damry N; Christophe C
    Pediatr Radiol; 2006 Mar; 36(3):205-12. PubMed ID: 16369780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pure methotrexate encephalopathy presenting with seizures: CT and MRI features.
    Lövblad K; Kelkar P; Ozdoba C; Ramelli G; Remonda L; Schroth G
    Pediatr Radiol; 1998 Feb; 28(2):86-91. PubMed ID: 9472050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.